Biome Grow Stock Number Of Shares Shorted
| BIOIF Stock | USD 0 0 48.65% |
Biome Grow fundamentals help investors to digest information that contributes to Biome Grow's financial success or failures. It also enables traders to predict the movement of Biome Pink Sheet. The fundamental analysis module provides a way to measure Biome Grow's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biome Grow pink sheet.
Biome |
Biome Grow Company Number Of Shares Shorted Analysis
Biome Grow's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Biome Grow has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Biome Fundamentals
| Return On Equity | -4.37 | |||
| Return On Asset | -0.0844 | |||
| Current Valuation | 2.98 M | |||
| Shares Outstanding | 112.42 M | |||
| Shares Owned By Insiders | 47.31 % | |||
| Price To Earning | 0.48 X | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 2.00 X | |||
| Gross Profit | 1.13 M | |||
| EBITDA | 313.61 K | |||
| Net Income | (139.93 K) | |||
| Cash And Equivalents | 2.1 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 3.51 M | |||
| Debt To Equity | 1.45 % | |||
| Current Ratio | 0.53 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (1.84 M) | |||
| Earnings Per Share | (0.15) X | |||
| Beta | 0.41 | |||
| Market Capitalization | 1.3 M | |||
| Total Asset | 11.07 M | |||
| Net Asset | 11.07 M |
About Biome Grow Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biome Grow's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biome Grow using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biome Grow based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Biome Pink Sheet
Biome Grow financial ratios help investors to determine whether Biome Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biome with respect to the benefits of owning Biome Grow security.